Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: One Small Pain Drug Maker And Three Biotech SPACs Launch IPOs

Sep 07 2020

• By Mandy Jackson

Finance Watch

Related Content

European Notebook: Industry’s Post-EU Election Goals; IMI2 Gets Under Way; FDA/EMA Tie-Up On Childhood Gaucher Studies

May 26 2014

$2bn AbbVie Deal Puts I-Mab On Global Immuno-Oncology Map

Sep 04 2020

Yselty For Uterine Fibroids Edges Closer To Being Obseva’s First Commercial Product

Jul 06 2020

Start-Up Quarterly Statistics: Relay, Cerevel Financings Lead Q4 VC Deals

Feb 05 2019

$3bn Roivant Deal To Fill Holes At Dainippon

Sep 06 2019

Mustang Leads Fortress's CAR-T Ambitions Of Monstrous Proportions

Jul 26 2017

New Company, Big Goal: Serial Entrepreneur Jonathan Lim Launches Erasca To 'Erase Cancer'

Dec 18 2018

Finance Watch: Early-Stage Firms Gain Deal-Making Insight As Golumbeski Joins VC Ranks

May 22 2018

Roivant Unveils An Autoimmune-Focused 'Vant' At Inaugural Pipeline Day

Jul 11 2018

Finance Watch: Investors Bet Billions On Big Biopharma Offerings

May 29 2020

Fortress Biotech: A Drug Financing Experiment Expands

Jun 13 2017

PainReform licenses Encore's post-surgical pain product

Jul 10 2008

Roche Ramps Up Cancer Portfolio With $1.7bn Ignyta Buy

Dec 22 2017

Intercept’s CRL Just Continues Upheaval In NASH

Jun 29 2020

Roche/Genentech Set Lower Rozlytrek Price To Catch Up With Bayer’s Vitrakvi

Aug 16 2019

Finance Watch: CureVac’s IPO Is Ready For Launch

Aug 11 2020

J&J Seeks Command Position In FcRn Space With Momenta Buyout

Aug 19 2020

Pipeline Watch: Phase III Readouts For Asciminib, Tesetaxel And Palovarotene

Sep 01 2020

Takeda/Ovid Plan Phase III For Soticlestat In Dravet Syndrome, But Pull Back On LGS

Aug 25 2020

EASL Updates: Intercept Says Biomarker Data Bolster OCA’s Case For Fibrosis Benefit

Aug 27 2020

Related Companies

PainReform Ltd.

Cerevel Therapeutics Holdings, Inc.

Immunovant, Inc.

Roivant Sciences Ltd.

Sumitomo Pharma Co., Ltd.

Johnson & Johnson

Momenta Pharmaceuticals, Inc.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

iNova Pharmaceuticals Pty. Ltd.

Odonate Therapeutics, Inc.

Fortress Biotech Inc.

Mustang Bio Inc.

Ovid Therapeutics, Inc.

BioCryst Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc.

Ignyta, Inc.

Roche Holding AG

Pyramid Biosciences, Inc.

BioVersys AG

GSK plc

Lumen Bioscience, Inc.

ObsEva SA

Rain Oncology Inc.

Daiichi Sankyo Co., Ltd.

InxMed Co., Ltd.

I-Mab

Additional Topics

Financing Growth Business Strategies Deals StartUps and SMEs Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.